• Featured Product
  • KD/KO Validated

CDK12/CRKRS Polyclonal antibody

CDK12/CRKRS Polyclonal Antibody for IF, WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IF, ELISA

Conjugate

Unconjugated

Cat no : 26816-1-AP

Synonyms

CDC2 related protein kinase 7, CDK12, CDK12/CRKRS, CRK7, CRKR, CRKRS, KIAA0904



Tested Applications

Positive WB detected inHeLa cells, K-562 cells, Jurkat cells
Positive IF detected inHeLa cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:2000-1:16000
Immunofluorescence (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 26816-1-AP is CDK12/CRKRS Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CDK12/CRKRS fusion protein Ag25323
Full Name Cdc2-related kinase, arginine/serine-rich
Calculated Molecular Weight 1490 aa, 164 kDa
Observed Molecular Weight 180-200 kDa
GenBank Accession NumberBC150265
Gene Symbol CRKRS
Gene ID (NCBI) 51755
RRIDAB_2880645
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

CRKRS (Cdc2-related kinase, Arg/Ser), also named as cyclin-dependent kinase 12 (CKD12), belongs to CDC2/CDKX subfamily. CDK12 can form a heterodimeric complex with its activating partner, cyclin K, to regulate important cellular physiological processes that include transcriptional regulation, regulation of DNA damage repair genes such as BRCA1 and ATM, suppression of intronic polyadenylation, and susceptibility to PARP inhibitors (PMID: 30487607, 24240700, 31694772). CDK12 has 3 isoforms with the calculated molecular mass of 164/163/141 kDa, and the apparent molecular mass of 180-200 kDa due to some modifications (PMID 11683387, 22988298).

Protocols

Product Specific Protocols
WB protocol for CDK12/CRKRS antibody 26816-1-APDownload protocol
IF protocol for CDK12/CRKRS antibody 26816-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Eur J Cancer

CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT.

Authors - Hui Li
humanWB

iScience

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate

Authors - Mareike Polenkowski
human

Int J Med Sci

Expression pattern of CDK12 protein in gastric cancer and its positive correlation with CD8+ cell density and CCL12 expression.

Authors - Jun Ji
humanWB

Cell Death Discov

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12.

Authors - Yan Liang
  • KD Validated

Reviews

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

M (Verified Customer) (06-29-2021)

No Signal at all at the right size. A couple of non specific bands showed up at lower molecular weights.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:1000
  • Cell Tissue Type: Human Liver lysate
CDK12/CRKRS Antibody Western Blot validation (1:1000 dilution) in Human Liver lysate (Cat no:26816-1-AP)